ISH-0613

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameISH-0613

Drug Alias NameISH-0988

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionB-lymphocyte inhibitorsInterferon alpha secretion inhibitors

TargetsInterferon alpha

Therapy Area/IndicationsLupus Erythematosus, Systemic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesSunHo (China) BioPharmaceutical Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSunHo (China) BioPharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsLupus Erythematosus, Systemic

Inactive IndicationsN/A

Other Information

ATC CodeN/A